NYSE:GRDN

Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis

Guardian Pharmacy Services logo
$50.39 +0.96 (+1.94%)
As of 03:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Guardian Pharmacy Services Stock (NYSE:GRDN)

Advanced

Key Stats

Today's Range
$49.20
▼
$50.80
50-Day Range
$39.08
▼
$50.01
52-Week Range
$26.34
▼
$50.80
Volume
156,821 shs
Average Volume
432,815 shs
Market Capitalization
$3.19 billion
P/E Ratio
42.96
Dividend Yield
N/A
Price Target
$45.57
Consensus Rating
Moderate Buy

Company Overview

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers.

The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care.

Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States. Fred Burke, a company co-founder, serves as its chief executive officer.

AI Generated. May Contain Errors.

Guardian Pharmacy Services Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

GRDN MarketRank™: 
1.64436199814 of 5 stars

Guardian Pharmacy Services scored higher than 33% of companies evaluated by MarketBeat, and ranked 740th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Guardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and no sell ratings.

  • Downside Risk

    Guardian Pharmacy Services has a consensus price target of $45.57, representing about 9.6% downside from its current price of $50.39.

  • Amount of Analyst Coverage

    Guardian Pharmacy Services has only been the subject of 3 research reports in the past 90 days.

  • Read more about Guardian Pharmacy Services' stock forecast and price target.
  • Earnings Growth

    Earnings for Guardian Pharmacy Services are expected to grow by 12.71% in the coming year, from $1.18 to $1.33 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Guardian Pharmacy Services is 42.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Guardian Pharmacy Services is 42.96, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.16.

  • Price to Earnings Growth Ratio

    Guardian Pharmacy Services has a PEG Ratio of 2.58. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Guardian Pharmacy Services has a P/B Ratio of 11.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.19% of the float of Guardian Pharmacy Services has been sold short.
  • Short Interest Ratio / Days to Cover

    Guardian Pharmacy Services has a short interest ratio ("days to cover") of 6.64.
  • Change versus previous month

    Short interest in Guardian Pharmacy Services has recently decreased by 7.50%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Guardian Pharmacy Services does not currently pay a dividend.

  • Dividend Growth

    Guardian Pharmacy Services does not have a long track record of dividend growth.

  • News Sentiment

    Guardian Pharmacy Services has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Guardian Pharmacy Services insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Guardian Pharmacy Services has minimal institutional ownership at this time.

  • Read more about Guardian Pharmacy Services' insider trading history.
Receive GRDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GRDN Stock News Headlines

Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Guardian Pharma (GRDN) Q3 2026 Earnings Call Transcript
See More Headlines

GRDN Stock Analysis - Frequently Asked Questions

Guardian Pharmacy Services' stock was trading at $30.01 at the start of the year. Since then, GRDN stock has increased by 67.9% and is now trading at $50.3890.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) released its quarterly earnings results on Thursday, November, 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.02. The business earned $371.07 million during the quarter, compared to analysts' expectations of $365.76 million. Guardian Pharmacy Services had a trailing twelve-month return on equity of 30.29% and a net margin of 5.13%.
Read the conference call transcript
.

Guardian Pharmacy Services (GRDN) raised $102 million in an IPO on Thursday, September 26th 2024. The company issued 6,800,000 shares at a price of $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO.

Top institutional shareholders of Guardian Pharmacy Services include State Street Corp (1.22%), First Trust Advisors LP (0.95%), Bessemer Group Inc. (1.14%) and Boston Partners (0.83%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, Kendall Forbes, John Ackerman, Equity Fund LP Cardinal, David K Morris and Steven D Cosler.
View institutional ownership trends
.

Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/05/2026
Today
11/17/2026
2026 Stephens Annual Investment Conference | NASH2026
11/18/2026
Citi Annual Global Healthcare Conference 2026
12/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:GRDN
Previous Symbol
NYSE:GRDN
CIK
1802255
Fax
N/A
Employees
3,600
Year Founded
2004

Price Target and Rating

High Price Target
$52.00
Low Price Target
$36.00
Potential Upside/Downside
-9.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.17
Trailing P/E Ratio
42.91
Forward P/E Ratio
37.68
P/E Growth
2.58
Net Income
$49.22 million
Net Margins
5.13%
Pretax Margin
7.22%
Return on Equity
30.29%
Return on Assets
16.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.33

Sales & Book Value

Annual Sales
$1.45 billion
Price / Sales
2.19
Cash Flow
$1.28 per share
Price / Cash Flow
39.21
Book Value
$4.42 per share
Price / Book
11.34

Miscellaneous

Outstanding Shares
63,320,000
Free Float
42,450,000
Market Cap
$3.17 billion
Optionable
Optionable
Beta
0.06

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NYSE:GRDN) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners